NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

藥物研發用AI(人工智能)市場:治療領域·用途·不同地區的預測 - 市場佔有率·市場規模·趨勢·產業分析(2021年∼2028年)

Artificial Intelligence in Drug Discovery Market Share, Size, Trends, Industry Analysis Report, By Therapeutic Area ; By Application; By Regions; Segment Forecast, 2021 - 2028

出版商 Polaris Market Research 商品編碼 1004384
出版日期 內容資訊 英文 106 Pages
商品交期: 最快1-2個工作天內
價格
藥物研發用AI(人工智能)市場:治療領域·用途·不同地區的預測 - 市場佔有率·市場規模·趨勢·產業分析(2021年∼2028年) Artificial Intelligence in Drug Discovery Market Share, Size, Trends, Industry Analysis Report, By Therapeutic Area ; By Application; By Regions; Segment Forecast, 2021 - 2028
出版日期: 2021年04月01日內容資訊: 英文 106 Pages
簡介

全球藥物研發用AI(人工智能)的市場規模在2028年之前預測將達到40億5,000萬美元。

各治療領域來看,腫瘤部門在 2020 年實現了最大的收入佔有率。AI(人工智能)在診斷癌症方面發揮著重要作用。

本報告提供全球藥物研發用AI(人工智能)市場相關調查,提供市場概要,治療領域·用途·各地區的市場規模的變化與預測,市場推動要素·阻礙因素分析,市場機會,課題,競爭情形,主要企業的簡介等全面性資訊。

目錄

第1章 簡介

  • 報告概要
    • 調查目的
    • 市場規模
    • 假設
  • 相關利益者

第2章 摘要整理

  • 市場概況

第3章 調查手法

  • 概要
    • 資料探勘
  • 資料來源
    • 一級資訊來源
    • 二級資訊來源

第4章 市場洞察

  • 產業概述
  • 市場動態
    • 推動要素和機會
    • 阻礙因素與課題
  • 波特的五力分析
    • 供給企業談判力(中)
    • 新加入廠商者的威脅(低)
    • 買方議價能力(中)
    • 替代品的威脅(中)
    • 競爭企業間的敵對關係(高)
  • 大環境分析
  • 產業趨勢
  • 新型冠狀病毒感染疾病(COVID-19)的影響

第5章 藥物研發用AI(人工智能)市場:各用途

  • 主要調查結果
  • 簡介
    • 市場規模:各用途(實際成果值·預測值)
  • 藥物最佳化·再利用
  • 臨床試驗前
  • 其他

第6章 藥物研發用AI(人工智能)市場:各治療領域

  • 主要調查結果
  • 簡介
    • 市場規模:各治療領域(實際成果值·預測值)
  • 腫瘤
  • 神經退化性疾病
  • 循環系統疾病
  • 代謝疾病
  • 感染疾病
  • 其他

第7章 藥物研發用AI(人工智能)市場:各地區

  • 主要調查結果
  • 簡介
  • 北美
    • 市場規模:各市場區隔(實際成果值·預測值)
    • 美國
    • 加拿大
  • 歐洲
    • 市場規模:各市場區隔(實際成果值·預測值)
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 奧地利
    • 其他
  • 亞太地區
    • 市場規模:各市場區隔(實際成果值·預測值)
    • 中國
    • 印度
    • 馬來西亞
    • 日本
    • 印尼
    • 韓國
  • 中東·非洲
    • 市場規模:各市場區隔(實際成果值·預測值)
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 以色列
  • 南美
    • 市場規模:各市場區隔(實際成果值·預測值)
    • 墨西哥
    • 巴西
    • 阿根廷

第8章 競爭情形

  • 擴大·收購
  • 夥伴關係·合作·契約·展示會

第9章 企業簡介

  • IBM Watson
  • Exscientia
  • GNS Healthcare
  • Alphabet (DeepMind)
  • Benevolent AI
  • BioSymetrics
  • Euretos
  • Berg Health
  • Atomwise
  • Cyclica
目錄
Product Code: PM1850

The global artificial intelligence (AI) in drug discovery market size is expected to reach USD 4.05 billion by 2028 according to a new study by Polaris Market Research. The report "Artificial Intelligence in Drug Discovery Market Share, Size, Trends, Industry Analysis Report, By Therapeutic Area (Oncology, Neurodegenerative Diseases, Cardiovascular Disease, Metabolic Diseases, Infectious Disease, Others); By Application; By Regions; Segment Forecast, 2021 - 2028" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Based on therapeutic areas, the global artificial intelligence (AI) in drug discovery market is segmented into oncology, neurodegenerative diseases, cardiovascular disease, metabolic diseases, infectious diseases, and others. In 2020, the oncology segment accounted for the largest revenue share. Artificial intelligence plays an important role in the pre-diagnosis of cancer. Cancer treatments vary from person to person and personalized medicine has played an important role.

Artificial intelligence (AI) platforms are designed to ascertain genetic mutations, helping oncologists in designing effective treatment plans. In this line, a Switzerland-based company, Sophia Genetics developed an AI platform that helps to identify tumors by detecting genetic variations and devising personalized cancer treatment plans.

However, the infectious disease segment of artificial intelligence (AI) in drug discovery industry is projected to witness a lucrative growth rate over the study period. The increasing adoption of artificial intelligence (AI) platforms in infectious diseases to identify key infection patterns. A positive scenario for the segment is also illustrated by key partnerships and collaborations in the market for artificial intelligence (AI) in drug discovery.

For instance, artificial intelligence (AI)-based drug discovery company, Existencia, entered into an agreement with Scripps Research to identify COVID-19 antiviral therapies. On the same ground, Google's Deepmind company also working on the artificial intelligence (AI) platform AlphaFold. The product is designed to provide information on several proteins involved in the diagnosis of SARS and COVID-19.

Market participants such as IBM Watson, Alphabet (DeepMind), Exscientia, GNS Healthcare, Insitro, BioSymetrics, Euretos, Berg Health, Benevolent AI, Atomwise, and Cyclica. are some of the key players operating in the global market. The companies in the artificial intelligence (AI) industry are involved in collaborations and partnerships with artificial intelligence (AI) platform providers to revolutionize medical treatment.

In this direction, in January 2021, the U.S.-based provider of biomarkers-based therapy, Nucleai signed a collaboration agreement with Debiopharm, pharma company pioneering in drug development. According to the agreement the latter will use Nucleai's artificial intelligence (AI) platform for its pipeline oncology drug candidates.

Polaris Market Research has segmented the artificial intelligence in drug discovery market report on the basis of application, therapeutic area, and region:

Artificial Intelligence in Drug Discovery, Application Outlook (Revenue - USD Million, 2016 - 2028)

Drug optimization and repurposing

Preclinical testing

Others

Artificial Intelligence in Drug Discovery, Therapeutic Area Outlook (Revenue - USD Million, 2016 - 2028)

Oncology

Neurodegenerative Diseases

Cardiovascular Disease

Metabolic Diseases

Infectious Disease

Others

Artificial Intelligence in Drug Discovery, Regional Outlook (Revenue - USD Million, 2016 - 2028)

North America

U.S.

Canada

Europe

France

Germany

UK

Italy

Spain

Netherlands

Austria

Asia Pacific

China

India

Japan

Malaysia

Australia

Indonesia

Central & South America

Mexico

Brazil

Argentina

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Artificial Intelligence in Drug Discovery Market Insights

  • 4.1. Artificial Intelligence in Drug Discovery - Industry snapshot
  • 4.2. Artificial Intelligence in Drug Discovery Market Dynamics
    • 4.2.1. Drivers and Opportunities
    • 4.2.2. Advancements in AI
    • 4.2.3. Rapid uptake in varied Therapeutic Areas
    • 4.2.4. Restraints and Challenges
    • 4.2.5. Data feeding issues
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Artificial Intelligence in Drug Discovery Market Industry trends
  • 4.6. COVID-19 Impact Analysis

5. Artificial Intelligence in Drug Discovery Market Assessment by Application

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Artificial Intelligence in Drug Discovery Market, By Application, 2016 - 2028 (USD Million)
  • 5.3. Drug optimization and repurposing
    • 5.3.1. Global Artificial Intelligence in Drug Discovery Market, by Drug optimization and repurposing, by Region, 2016 - 2028 (USD Million)
  • 5.4. Preclinical testing
    • 5.4.1. Global Artificial Intelligence in Preclinical testing Market, by eMBB, by Region, 2016 - 2028 (USD Million)
  • 5.5. Others
    • 5.5.1. Global Artificial Intelligence in Drug Discovery Market, by Others, by Region, 2016 - 2028 (USD Million)

6. Global Artificial Intelligence in Drug Discovery Market, by Therapeutic Area

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 - 2028 (USD Million)
  • 6.3. Oncology
    • 6.3.1. Global Artificial Intelligence in Drug Discovery Market, by Oncology, By Region, 2016 - 2028 (USD Million)
  • 6.4. Neurodegenerative Diseases
    • 6.4.1. Global Artificial Intelligence in Drug Discovery Market, by Neurodegenerative Diseases, by Region, 2016 - 2028 (USD Million)
  • 6.5. Cardiovascular Disease
    • 6.5.1. Global Artificial Intelligence in Drug Discovery Market, by Cardiovascular Disease, by Region, 2016 - 2028 (USD Million)
  • 6.6. Metabolic Diseases
    • 6.6.1. Global Artificial Intelligence in Drug Discovery Market, by Metabolic Diseases, by Region, 2016 - 2028 (USD Million)
  • 6.7. Infectious Disease
    • 6.7.1. Global Artificial Intelligence in Drug Discovery Market, by Infectious Disease, by Region, 2016 - 2028 (USD Million)
  • 6.8. Others
    • 6.8.1. Global Artificial Intelligence in Drug Discovery Market, by Others, by Region, 2016 - 2028 (USD Million)

7. Artificial Intelligence in Drug Discovery Market Assessment by Geography

  • 7.1. Key findings
  • 7.2. Introduction
    • 7.2.1. Artificial Intelligence in Drug Discovery Market Assessment, By Geography, 2016 - 2028 (USD Million)
  • 7.3. Artificial Intelligence in Drug Discovery Market - North America
    • 7.3.1. North America: Artificial Intelligence in Drug Discovery Market, By Application, 2016 - 2028 (USD Million)
    • 7.3.2. North America: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 - 2028 (USD Million)
    • 7.3.3. Artificial Intelligence in Drug Discovery Market - U.S.
      • 7.3.3.1. U.S.: Artificial Intelligence in Drug Discovery Market, By Application, 2016 - 2028 (USD Million)
      • 7.3.3.2. U.S.: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 - 2028 (USD Million)
    • 7.3.4. Artificial Intelligence in Drug Discovery Market - Canada
      • 7.3.4.1. Canada: Artificial Intelligence in Drug Discovery Market, By Application, 2016 - 2028 (USD Million)
      • 7.3.4.2. Canada.: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 - 2028 (USD Million)
  • 7.4. Artificial Intelligence in Drug Discovery Market - Europe
    • 7.4.1. Europe: Artificial Intelligence in Drug Discovery Market, By Application, 2016 - 2028 (USD Million)
    • 7.4.2. Europe: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 - 2028 (USD Million)
    • 7.4.3. Artificial Intelligence in Drug Discovery Market - UK
      • 7.4.3.1. UK: Artificial Intelligence in Drug Discovery Market, By Application, 2016 - 2028 (USD Million)
      • 7.4.3.2. UK: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 - 2028 (USD Million)
    • 7.4.4. Artificial Intelligence in Drug Discovery Market - France
      • 7.4.4.1. France: Artificial Intelligence in Drug Discovery Market, By Application, 2016 - 2028 (USD Million)
      • 7.4.4.2. France: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 - 2028 (USD Million)
    • 7.4.5. Artificial Intelligence in Drug Discovery Market - Germany
      • 7.4.5.1. Germany: Artificial Intelligence in Drug Discovery Market, By Application, 2016 - 2028 (USD Million)
      • 7.4.5.2. Germany: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 - 2028 (USD Million)
    • 7.4.6. Artificial Intelligence in Drug Discovery Market - Italy
      • 7.4.6.1. Italy: Artificial Intelligence in Drug Discovery Market, By Application, 2016 - 2028 (USD Million)
      • 7.4.6.2. Italy: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 - 2028 (USD Million)
    • 7.4.7. Artificial Intelligence in Drug Discovery Market - Spain
      • 7.4.7.1. Spain: Artificial Intelligence in Drug Discovery Market, By Application, 2016 - 2028 (USD Million)
      • 7.4.7.2. Spain: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 - 2028 (USD Million)
    • 7.4.8. Artificial Intelligence in Drug Discovery Market - Netherlands
      • 7.4.8.1. Netherlands: Artificial Intelligence in Drug Discovery Market, By Application, 2016 - 2028 (USD Million)
      • 7.4.8.2. Netherlands: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 - 2028 (USD Million)
    • 7.4.9. Artificial Intelligence in Drug Discovery Market - Austria
      • 7.4.9.1. Austria: Artificial Intelligence in Drug Discovery Market, By Application, 2016 - 2028 (USD Million)
      • 7.4.9.2. Austria: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 - 2028 (USD Million)
  • 7.5. Artificial Intelligence in Drug Discovery Market - Asia-Pacific
    • 7.5.1. Asia Pacific: Artificial Intelligence in Drug Discovery Market, By Application, 2016 - 2028 (USD Million)
    • 7.5.2. Asia Pacific: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 - 2028 (USD Million)
    • 7.5.3. Artificial Intelligence in Drug Discovery Market - China
      • 7.5.3.1. China: Artificial Intelligence in Drug Discovery Market, By Application, 2016 - 2028 (USD Million)
      • 7.5.3.2. China: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 - 2028 (USD Million)
    • 7.5.4. Artificial Intelligence in Drug Discovery Market - India
      • 7.5.4.1. India: Artificial Intelligence in Drug Discovery Market, By Application, 2016 - 2028 (USD Million)
      • 7.5.4.2. India.: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 - 2028 (USD Million)
    • 7.5.5. Artificial Intelligence in Drug Discovery Market - Malaysia
      • 7.5.5.1. Malaysia: Artificial Intelligence in Drug Discovery Market, By Application, 2016 - 2028 (USD Million)
      • 7.5.5.2. Malaysia: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 - 2028 (USD Million)
    • 7.5.6. Artificial Intelligence in Drug Discovery Market - Japan
      • 7.5.6.1. Japan: Artificial Intelligence in Drug Discovery Market, By Application, 2016 - 2028 (USD Million)
      • 7.5.6.2. Japan: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 - 2028 (USD Million)
    • 7.5.7. Artificial Intelligence in Drug Discovery Market - Indonesia
      • 7.5.7.1. Indonesia: Artificial Intelligence in Drug Discovery Market, By Application, 2016 - 2028 (USD Million)
      • 7.5.7.2. Indonesia: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 - 2028 (USD Million)
    • 7.5.8. Artificial Intelligence in Drug Discovery Market - South Korea
      • 7.5.8.1. South Korea: Artificial Intelligence in Drug Discovery Market, By Application, 2016 - 2028 (USD Million)
      • 7.5.8.2. South Korea.: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 - 2028 (USD Million)
  • 7.6. Artificial Intelligence in Drug Discovery Market - Middle East & Africa
    • 7.6.1. Middle East & Africa: Artificial Intelligence in Drug Discovery Market, By Application, 2016 - 2028 (USD Million)
    • 7.6.2. Middle East & Africa.: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 - 2028 (USD Million)
    • 7.6.3. Artificial Intelligence in Drug Discovery Market - Saudi Arabia
      • 7.6.3.1. Saudi Arabia: Artificial Intelligence in Drug Discovery Market, By Application, 2016 - 2028 (USD Million)
      • 7.6.3.2. Saudi Arabia.: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 - 2028 (USD Million)
    • 7.6.4. Artificial Intelligence in Drug Discovery Market - UAE
      • 7.6.4.1. UAE: Artificial Intelligence in Drug Discovery Market, By Application, 2016 - 2028 (USD Million)
      • 7.6.4.2. UAE: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 - 2028 (USD Million)
    • 7.6.5. Artificial Intelligence in Drug Discovery Market - Israel
      • 7.6.5.1. Israel: Artificial Intelligence in Drug Discovery Market, By Application, 2016 - 2028 (USD Million)
      • 7.6.5.2. Israel: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 - 2028 (USD Million)
    • 7.6.6. Artificial Intelligence in Drug Discovery Market - South Africa
      • 7.6.6.1. South Africa: Artificial Intelligence in Drug Discovery Market, By Application, 2016 - 2028 (USD Million)
      • 7.6.6.2. South Africa: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 - 2028 (USD Million)
  • 7.7. Artificial Intelligence in Drug Discovery Market - Latin America
    • 7.7.1. Latin America: Artificial Intelligence in Drug Discovery Market, By Application, 2016 - 2028 (USD Million)
    • 7.7.2. Latin America: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 - 2028 (USD Million)
    • 7.7.3. Artificial Intelligence in Drug Discovery Market - Mexico
      • 7.7.3.1. Mexico: Artificial Intelligence in Drug Discovery Market, By Application, 2016 - 2028 (USD Million)
      • 7.7.3.2. Mexico.: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 - 2028 (USD Million)
    • 7.7.4. Artificial Intelligence in Drug Discovery Market - Brazil
      • 7.7.4.1. Brazil: Artificial Intelligence in Drug Discovery Market, By Application, 2016 - 2028 (USD Million)
      • 7.7.4.2. Brazil.: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 - 2028 (USD Million)
    • 7.7.5. Artificial Intelligence in Drug Discovery Market - Argentina
      • 7.7.5.1. Argentina: Artificial Intelligence in Drug Discovery Market, By Application, 2016 - 2028 (USD Million)
      • 7.7.5.2. Argentina.: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 - 2028 (USD Million)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisition
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. IBM Watson
    • 9.1.1. Company Overview
    • 9.1.2. Financial Performance
    • 9.1.3. Product & Services Benchmarking
    • 9.1.4. Recent Development
  • 9.2. Exscientia
    • 9.2.1. Company Overview
    • 9.2.2. Financial Performance
    • 9.2.3. Product & Services Benchmarking
    • 9.2.4. Recent Development
  • 9.3. GNS Healthcare
    • 9.3.1. Company Overview
    • 9.3.2. Financial Performance
    • 9.3.3. Product & Services Benchmarking
    • 9.3.4. Recent Development
  • 9.4. Alphabet (DeepMind)
    • 9.4.1. Company Overview
    • 9.4.2. Financial Performance
    • 9.4.3. Product & Services Benchmarking
    • 9.4.4. Recent Development
  • 9.5. Benevolent AI
    • 9.5.1. Company Overview
    • 9.5.2. Financial Performance
    • 9.5.3. Product & Services Benchmarking
    • 9.5.4. Recent Development
  • 9.6. BioSymetrics
    • 9.6.1. Company Overview
    • 9.6.2. Financial Performance
    • 9.6.3. Product & Services Benchmarking
    • 9.6.4. Recent Development
  • 9.7. Euretos
    • 9.7.1. Company Overview
    • 9.7.2. Financial Performance
    • 9.7.3. Product & Services Benchmarking
    • 9.7.4. Recent Development
  • 9.8. Berg Health
    • 9.8.1. Company Overview
    • 9.8.2. Financial Performance
    • 9.8.3. Product & Services Benchmarking
    • 9.8.4. Recent Development
  • 9.9. Atomwise
    • 9.9.1. Company Overview
    • 9.9.2. Financial Performance
    • 9.9.3. Product & Services Benchmarking
    • 9.9.4. Recent Development
  • 9.10. Cyclica
    • 9.10.1. Company Overview
    • 9.10.2. Financial Performance
    • 9.10.3. Product & Services Benchmarking
    • 9.10.4. Recent Development

List of Tables

  • Table 1 Global Artificial Intelligence in Drug Discovery Market, By Application, 2016 - 2028 (USD Million)
  • Table 2 Global Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 - 2028 (USD Million)
  • Table 3 Artificial Intelligence in Drug Discovery Market Assessment, By Geography, 2016 - 2028 (USD Million)
  • Table 4 North America: Artificial Intelligence in Drug Discovery Market, By Application, 2016 - 2028 (USD Million)
  • Table 5 North America: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 - 2028 (USD Million)
  • Table 6 U.S.: Artificial Intelligence in Drug Discovery Market, By Application, 2016 - 2028 (USD Million)
  • Table 7 U.S.: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 - 2028 (USD Million)
  • Table 8 Canada: Artificial Intelligence in Drug Discovery Market, By Application, 2016 - 2028 (USD Million)
  • Table 9 Canada: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 - 2028 (USD Million)
  • Table 10 Europe: Artificial Intelligence in Drug Discovery Market, By Application, 2016 - 2028 (USD Million)
  • Table 11 Europe: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 - 2028 (USD Million)
  • Table 12 UK: Artificial Intelligence in Drug Discovery Market, By Application, 2016 - 2028 (USD Million)
  • Table 13 UK: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 - 2028 (USD Million)
  • Table 14 France: Artificial Intelligence in Drug Discovery Market, By Application, 2016 - 2028 (USD Million)
  • Table 15 France: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 - 2028 (USD Million)
  • Table 16 Germany: Artificial Intelligence in Drug Discovery Market, By Application, 2016 - 2028 (USD Million)
  • Table 17 Germany: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 - 2028 (USD Million)
  • Table 18 Italy: Artificial Intelligence in Drug Discovery Market, By Application, 2016 - 2028 (USD Million)
  • Table 19 Italy: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 - 2028 (USD Million)
  • Table 20 Spain: Artificial Intelligence in Drug Discovery Market, By Application, 2016 - 2028 (USD Million)
  • Table 21 Spain: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 - 2028 (USD Million)
  • Table 22 Netherlands: Artificial Intelligence in Drug Discovery Market, By Application, 2016 - 2028 (USD Million)
  • Table 23 Netherlands: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 - 2028 (USD Million)
  • Table 24 Austria: Artificial Intelligence in Drug Discovery Market, By Application, 2016 - 2028 (USD Million)
  • Table 25 Austria: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 - 2028 (USD Million)
  • Table 26 Asia Pacific: Artificial Intelligence in Drug Discovery Market, By Application, 2016 - 2028 (USD Million)
  • Table 27 Asia Pacific: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 - 2028 (USD Million)
  • Table 28 China: Artificial Intelligence in Drug Discovery Market, By Application, 2016 - 2028 (USD Million)
  • Table 29 China: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 - 2028 (USD Million)
  • Table 30 India: Artificial Intelligence in Drug Discovery Market, By Application, 2016 - 2028 (USD Million)
  • Table 31 India: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 - 2028 (USD Million)
  • Table 32 Malaysia: Artificial Intelligence in Drug Discovery Market, By Application, 2016 - 2028 (USD Million)
  • Table 33 Malaysia: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 - 2028 (USD Million)
  • Table 34 Japan: Artificial Intelligence in Drug Discovery Market, By Application, 2016 - 2028 (USD Million)
  • Table 35 Japan: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 - 2028 (USD Million)
  • Table 36 Indonesia: Artificial Intelligence in Drug Discovery Market, By Application, 2016 - 2028 (USD Million)
  • Table 37 Indonesia: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 - 2028 (USD Million)
  • Table 38 South Korea: Artificial Intelligence in Drug Discovery Market, By Application, 2016 - 2028 (USD Million)
  • Table 39 South Korea: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 - 2028 (USD Million)
  • Table 40 Middle East & Africa: Artificial Intelligence in Drug Discovery Market, By Application, 2016 - 2028 (USD Million)
  • Table 41 Middle East & Africa: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 - 2028 (USD Million)
  • Table 42 Saudi Arabia: Artificial Intelligence in Drug Discovery Market, By Application, 2016 - 2028 (USD Million)
  • Table 43 Saudi Arabia: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 - 2028 (USD Million)
  • Table 44 UAE: Artificial Intelligence in Drug Discovery Market, By Application, 2016 - 2028 (USD Million)
  • Table 45 UAE: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 - 2028 (USD Million)
  • Table 46 Israel: Artificial Intelligence in Drug Discovery Market, By Application, 2016 - 2028 (USD Million)
  • Table 47 Israel: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 - 2028 (USD Million)
  • Table 48 South Africa: Artificial Intelligence in Drug Discovery Market, By Application, 2016 - 2028 (USD Million)
  • Table 49 South Africa: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 - 2028 (USD Million)
  • Table 50 Latin America: Artificial Intelligence in Drug Discovery Market, By Application, 2016 - 2028 (USD Million)
  • Table 51 Latin America: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 - 2028 (USD Million)
  • Table 52 Mexico: Artificial Intelligence in Drug Discovery Market, By Application, 2016 - 2028 (USD Million)
  • Table 53 Mexico: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 - 2028 (USD Million)
  • Table 54 Brazil: Artificial Intelligence in Drug Discovery Market, By Application, 2016 - 2028 (USD Million)
  • Table 55 Brazil: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 - 2028 (USD Million)
  • Table 56 Argentina: Artificial Intelligence in Drug Discovery Market, By Application, 2016 - 2028 (USD Million)
  • Table 57 Argentina: Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2016 - 2028 (USD Million)

List of Figures

Figure 1 Market Highlights (2020, Revenue)

Figure 2 Integrated Ecosystem

Figure 3 Research Methodology: Top Down & Bottom Up Approach

Figure 4 Market by Geography

Figure 5 Porter's Five Forces

Figure 6 Market by Application

Figure 7 Global Artificial Intelligence in Drug Discovery Market, By Application, 2020 & 2028 (USD Million)

Figure 8 Market by Therapeutic Area

Figure 9 Global Artificial Intelligence in Drug Discovery Market, By Therapeutic Area, 2020 & 2028 (USD Million)

Figure 10 Artificial Intelligence in Drug Discovery Market Assessment, By Geography, 2016 - 2028 (USD Million)

Figure 11 Strategic Analysis - Artificial Intelligence in Drug Discovery Market